Developer docs
API playgroundTry for free, no card

Search company profiles

Lura Health

Full company profile

uuid0000irg

Namestring
Lura Health
Legal namestring
Lura Health
Websiteurl
lurahealth.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Lura Health is a pre-commercial medical device company developing a miniaturized salivary microbiosensor that is worn in the mouth — either integrated into dental hardware such as clear plastic trays, sports guards, Hawley retainers, brackets and bands, dentures, and crowns, or attached directly to a tooth for up to 18 months. The sensor continuously records analytes in saliva related to chronic conditions including diabetes and hypertension, transmitting data to a patient's smartphone via Bluetooth Low Energy and onward to electronic medical record systems for clinician review. The company positions its product as the world's first continuous health monitoring platform powered by saliva, targeting three primary segments: chronic disease patients seeking non-invasive alternatives to blood-based monitoring, healthcare providers needing continuous data for treatment decisions, and the dental industry (DSOs, dentists, and dental product manufacturers) seeking to add health-monitoring capabilities to existing dental workflows.

Underlying technology centers on a proprietary micro-sensor smaller than a tube of lipstick that measures hundreds of health and disease markers including glucose, electrolytes, and biologics, with wireless connectivity powered by Silicon Labs' XG27 Bluetooth chip. Hardware development is supported by a partnership with Resonant Link for device miniaturization. Lura Health's planned business model combines hardware device sales, recurring data and analytics services delivered to providers via dashboards, and OEM/embedded licensing arrangements with dental hardware manufacturers.

As of the input data, the product is in development and explicitly not approved for sale or distribution in the USA, with revenue undisclosed. The company is venture-capital and NSF-backed, has raised approximately $1.2M in non-dilutive NSF funding supplemented by a $75K state grant, undisclosed SOSV seed equity, and an undisclosed August 2025 strategic investment from SCO Group. The team of 1–10 employees operates from HAX's Newark, NJ facility and is led by Co-Founder/CEO Daniel Weinstein and Co-Founder/CMO Dr. Saam Bozorg, with Forbes 30 Under 30 recognition in 2023 underscoring early-stage visibility.

Short descriptiontext

Lura Health is a pre-commercial medical device company developing a miniaturized intraoral salivary biosensor that continuously monitors chronic disease biomarkers and transmits data via Bluetooth to smartphones and EMR systems for patients, providers, and dental industry partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
salivary diagnostics platform, continuous health monitoring, wearable biosensor devices, remote patient monitoring, chronic disease management
Industry2 codes
1Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
CodeHLACAPABPrimaryYes
2Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
CodeHLACAPAIPrimaryNo
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Wearable Medical Biosensors
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Hardware Device Sales
TypeHardware Sales
Description

Sale of the miniaturized salivary health monitoring sensor integrated into dental products. Product is currently in development and not yet approved for sale or distribution in the USA.

lurahealth.com
2Data/Analytics Services
TypeSubscription Recurring
Description

Long-term health data analysis and patient-specific insights shared with healthcare providers, enabling predictive and preventive care dashboards for practitioners.

lurahealth.com
3OEM/Embedded Licensing
TypeLicensing Royalties
Description

Integration of sensor technology into existing dental hardware manufacturers' products (aligners, toothbrushes, etc.), potentially through licensing arrangements.

lurahealth.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Lura Health is developing a non-invasive, miniaturized microbiosensor worn in the mouth that continuously records salivary analytes (glucose, electrolytes, biologics) related to chronic disease and transmits the data to a smartphone via Bluetooth Low Energy. The sensor can be integrated into existing dental hardware such as aligners, retainers, sports guards, brackets, dentures, crowns, and bridges, or attached directly to a tooth for up to 18 months, with readings linked to electronic medical records for clinician review. The product is currently in development and is not yet approved for sale or distribution in the USA.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Addresses $4.1 trillion in annual chronic disease healthcare costs through continuous monitoring enabling proactive management
+2 more records
Product overview1 text field

Lura Health is developing a single unified product: a non-invasive, saliva-based continuous health monitoring platform. The core offering consists of a microbiosensor (smaller than a tube of lipstick) worn in the mouth that continually measures salivary biomarkers (such as glucose, electrolytes, and biologics) related to chronic diseases like diabetes and hypertension. Data is automatically transmitted via Bluetooth Low Energy to a patient's smartphone and can be shared with healthcare providers through electronic medical records systems. The sensor can be integrated into various dental hardware products (clear plastic trays, sports guards, Hawley retainers, brackets and bands, dentures and partials, crowns and bridges) or attached directly to a tooth for up to 18 months. The product is currently in development and not approved for sale or distribution in the USA.

Product and service1 record
1Lura Health Monitoring System
CategoryWearable Health Monitoring Device
Description

A miniaturized intraoral microbiosensor (smaller than a tube of lipstick) that continuously records salivary analytes such as glucose, electrolytes, and biologics related to chronic disease, transmitting data via Bluetooth Low Energy to a smartphone app and integrating with electronic medical records for clinician review. It can be integrated into dental hardware including aligners, sports guards, Hawley retainers, brackets and bands, dentures and partials, and crowns and bridges, or painlessly attached directly to a tooth for up to 18 months. The product is in development and not yet approved for sale or distribution in the USA.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Hardware startup accelerator and coworking space partner. Lura Health operates out of HAX's 35,000 sq. ft. Newark facility with full engineering workshops and wet labs. Company showcased at HAX Demo Day.

Strategic tierStrategicTypeTechnology or Integration
Description

Partnership to redefine preventative care through development of miniaturized diagnostic device. Resonant Link provided case study collaboration on device development.

Strategic tierStrategicTypeTechnology or Integration
Description

Technology partnership for Bluetooth chip powering the tooth-mounted salivary health monitor. Using Silicon Labs XG27 chip and SDKs for wireless connectivity.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Dr. Maria Ryan, EVP & Chief Clinical Officer at Colgate, discussed Lura Health's predictive healthcare technology at CareQuest showcase. Colgate focuses on preventive care and oral-systemic health integration.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Partnership through participation in CareQuest Systemic Health Innovation Showcase. CareQuest focuses on improving oral health access and integrating oral-systemic health technologies.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Selected for AGA and MATTER inaugural incubator cohort focused on digestive health innovation and digital health products.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Healthcare innovation hub and startup incubator. Lura Health is a member of the MATTER startup community and co-hosts programs with AGA.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

New Jersey biotech industry association. Lura Health presented at BioNJ AI & Digital Health Day and is a member organization.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Joined DiMe's Integrated Evidence Plans (IEP) for Digital Health Products initiative to advance digital health evidence generation.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Dental and medical-dental integration investor. Lura Health featured at Revere Partners' Future of Dentistry Pavilion at Yankee Dental Congress.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Develops the Eversense implantable CGM with up to 180-day wear — the closest existing analog to Lura's long-duration (18-month) intraoral sensor concept. Both are pursuing long-duration continuous monitoring form factors.

TypeDirect peer
Description

Market leader in continuous glucose monitoring (CGM) with devices like the G7. Most directly comparable peer for continuous, real-time biomarker monitoring of chronic disease patients, although Lura is saliva-based and Dexcom is interstitial fluid-based.

TypeDirect peer
Description

Developer of intradermal, miniaturized continuous biosensor patches for metabolic biomarkers including glucose. Comparable in form-factor miniaturization and continuous biomarker mission.

TypeDirect peer
Description

Develops injectable, hydrogel-based biosensors that continuously monitor multiple analytes in interstitial fluid for months at a time. Comparable miniaturized, long-duration continuous biosensor platform targeting chronic disease.

TypeEmerging player
Description

Early-stage saliva-based diagnostics company developing at-home saliva tests for hormone and wellness biomarkers. Comparable diagnostic fluid (saliva) and consumer health focus, but episodic rather than continuous.

TypeBroad incumbent
Description

Diversified medical device leader with connected diabetes (MiniMed CGM and pumps) and broader patient monitoring portfolio. Comparable as a broad incumbent pursuing connected chronic disease monitoring at scale.

TypeDirect peer
Description

Saliva- and stool-based diagnostics company focused on gut microbiome, chronic disease and cancer detection. Most directly comparable saliva-based diagnostics peer, though Viome uses episodic lab testing versus Lura's continuous in-mouth sensor.

8Hagar Technology
TypeDirect peer
Description

Develops GWave, a non-invasive RF-based continuous glucose monitor. Directly comparable as a non-invasive continuous glucose alternative to Lura's saliva-based approach.

TypeBroad incumbent
Description

Global oral care leader publicly aligned with Lura (via Dr. Maria Ryan at CareQuest showcase) and actively pursuing oral-systemic health integration. Comparable as a potential OEM channel partner and adjacent oral-health hardware player.

TypeDirect peer
Description

Sells the FreeStyle Libre CGM line, the largest installed-base continuous glucose monitor globally. Comparable to Lura in continuous biomarker tracking for diabetes management and chronic disease.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lura Health

Wearable Medical Biosensorslurahealth.com

Lura Health is a pre-commercial medical device company developing a miniaturized intraoral salivary biosensor that continuously monitors chronic disease biomarkers and transmits data via Bluetooth to smartphones and EMR systems for patients, providers, and dental industry partners.

What Lura Health does

Lura Health is a pre-commercial medical device company developing a miniaturized salivary microbiosensor that is worn in the mouth — either integrated into dental hardware such as clear plastic trays, sports guards, Hawley retainers, brackets and bands, dentures, and crowns, or attached directly to a tooth for up to 18 months. The sensor continuously records analytes in saliva related to chronic conditions including diabetes and hypertension, transmitting data to a patient's smartphone via Bluetooth Low Energy and onward to electronic medical record systems for clinician review. The company positions its product as the world's first continuous health monitoring platform powered by saliva, targeting three primary segments: chronic disease patients seeking non-invasive alternatives to blood-based monitoring, healthcare providers needing continuous data for treatment decisions, and the dental industry (DSOs, dentists, and dental product manufacturers) seeking to add health-monitoring capabilities to existing dental workflows.

Underlying technology centers on a proprietary micro-sensor smaller than a tube of lipstick that measures hundreds of health and disease markers including glucose, electrolytes, and biologics, with wireless connectivity powered by Silicon Labs' XG27 Bluetooth chip. Hardware development is supported by a partnership with Resonant Link for device miniaturization. Lura Health's planned business model combines hardware device sales, recurring data and analytics services delivered to providers via dashboards, and OEM/embedded licensing arrangements with dental hardware manufacturers.

As of the input data, the product is in development and explicitly not approved for sale or distribution in the USA, with revenue undisclosed. The company is venture-capital and NSF-backed, has raised approximately $1.2M in non-dilutive NSF funding supplemented by a $75K state grant, undisclosed SOSV seed equity, and an undisclosed August 2025 strategic investment from SCO Group. The team of 1–10 employees operates from HAX's Newark, NJ facility and is led by Co-Founder/CEO Daniel Weinstein and Co-Founder/CMO Dr. Saam Bozorg, with Forbes 30 Under 30 recognition in 2023 underscoring early-stage visibility.

Lura Health firmographics

Firmographics
Name
Lura Health
Legal name
Lura Health
Website
https://lurahealth.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
Lura Health is a pre-commercial medical device company developing a miniaturized intraoral salivary biosensor that continuously monitors chronic disease biomarkers and transmits data via Bluetooth to smartphones and EMR systems for patients, providers, and dental industry partners.
Ownership category
akta.pro rank

Lura Health industry classification

Industry
Product category
Wearable Medical Biosensors
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)
akta.pro secondary industry
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

Keywords

  • Salivary diagnostics platform
  • Continuous health monitoring
  • Wearable biosensor devices
  • Remote patient monitoring
  • Chronic disease management

Where Lura Health is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Lura Health business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Hardware Device Sales: Sale of the miniaturized salivary health monitoring sensor integrated into dental products. Product is currently in development and not yet approved for sale or distribution in the USA.
  2. Data/Analytics Services: Long-term health data analysis and patient-specific insights shared with healthcare providers, enabling predictive and preventive care dashboards for practitioners.
  3. OEM/Embedded Licensing: Integration of sensor technology into existing dental hardware manufacturers' products (aligners, toothbrushes, etc.), potentially through licensing arrangements.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels6 records

Lura Health product offering

Product offering

Core offering

Lura Health is developing a non-invasive, miniaturized microbiosensor worn in the mouth that continuously records salivary analytes (glucose, electrolytes, biologics) related to chronic disease and transmits the data to a smartphone via Bluetooth Low Energy. The sensor can be integrated into existing dental hardware such as aligners, retainers, sports guards, brackets, dentures, crowns, and bridges, or attached directly to a tooth for up to 18 months, with readings linked to electronic medical records for clinician review. The product is currently in development and is not yet approved for sale or distribution in the USA.

Product overview

Lura Health is developing a single unified product: a non-invasive, saliva-based continuous health monitoring platform. The core offering consists of a microbiosensor (smaller than a tube of lipstick) worn in the mouth that continually measures salivary biomarkers (such as glucose, electrolytes, and biologics) related to chronic diseases like diabetes and hypertension. Data is automatically transmitted via Bluetooth Low Energy to a patient's smartphone and can be shared with healthcare providers through electronic medical records systems. The sensor can be integrated into various dental hardware products (clear plastic trays, sports guards, Hawley retainers, brackets and bands, dentures and partials, crowns and bridges) or attached directly to a tooth for up to 18 months. The product is currently in development and not approved for sale or distribution in the USA.

Differentiator

Problem solved

Functional benefit

Products and services

  • Lura Health Monitoring System A miniaturized intraoral microbiosensor (smaller than a tube of lipstick) that continuously records salivary analytes such as glucose, electrolytes, and biologics related to chronic disease, transmitting data via Bluetooth Low Energy to a smartphone app and integrating with electronic medical records for clinician review. It can be integrated into dental hardware including aligners, sports guards, Hawley retainers, brackets and bands, dentures and partials, and crowns and bridges, or painlessly attached directly to a tooth for up to 18 months. The product is in development and not yet approved for sale or distribution in the USA.

Quantifiable outcome

  • Addresses $4.1 trillion in annual chronic disease healthcare costs through continuous monitoring enabling proactive management
  • +2 more outcomes

Companies that use Lura Health

Customer profile

Segments3 records

Ideal customer profiles1 record

Lura Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Lura Health partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core, strategic and minor.

  • HAXcoreStrategic or Co-development PartnerHardware startup accelerator and coworking space partner. Lura Health operates out of HAX's 35,000 sq. ft. Newark facility with full engineering workshops and wet labs. Company showcased at HAX Demo Day.
  • Resonant LinkstrategicTechnology or IntegrationPartnership to redefine preventative care through development of miniaturized diagnostic device. Resonant Link provided case study collaboration on device development.
  • Silicon LabsstrategicTechnology or IntegrationTechnology partnership for Bluetooth chip powering the tooth-mounted salivary health monitor. Using Silicon Labs XG27 chip and SDKs for wireless connectivity.
  • Colgate-PalmolivestrategicStrategic or Co-development PartnerDr. Maria Ryan, EVP & Chief Clinical Officer at Colgate, discussed Lura Health's predictive healthcare technology at CareQuest showcase. Colgate focuses on preventive care and oral-systemic health integration.
  • CareQuest Institute for Oral HealthstrategicStrategic or Co-development PartnerPartnership through participation in CareQuest Systemic Health Innovation Showcase. CareQuest focuses on improving oral health access and integrating oral-systemic health technologies.
  • American Gastroenterological Association (AGA)strategicStrategic or Co-development PartnerSelected for AGA and MATTER inaugural incubator cohort focused on digestive health innovation and digital health products.
  • MATTERstrategicStrategic or Co-development PartnerHealthcare innovation hub and startup incubator. Lura Health is a member of the MATTER startup community and co-hosts programs with AGA.
  • BioNJminorStrategic or Co-development PartnerNew Jersey biotech industry association. Lura Health presented at BioNJ AI & Digital Health Day and is a member organization.
  • Digital Medicine Society (DiMe)strategicStrategic or Co-development PartnerJoined DiMe's Integrated Evidence Plans (IEP) for Digital Health Products initiative to advance digital health evidence generation.
  • Revere PartnersminorStrategic or Co-development PartnerDental and medical-dental integration investor. Lura Health featured at Revere Partners' Future of Dentistry Pavilion at Yankee Dental Congress.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Lura Health competitors and assessment

Company assessment

Direct peers

  • Senseonics: Develops the Eversense implantable CGM with up to 180-day wear — the closest existing analog to Lura's long-duration (18-month) intraoral sensor concept. Both are pursuing long-duration continuous monitoring form factors.
  • Dexcom: Market leader in continuous glucose monitoring (CGM) with devices like the G7. Most directly comparable peer for continuous, real-time biomarker monitoring of chronic disease patients, although Lura is saliva-based and Dexcom is interstitial fluid-based.
  • Biolinq: Developer of intradermal, miniaturized continuous biosensor patches for metabolic biomarkers including glucose. Comparable in form-factor miniaturization and continuous biomarker mission.
  • Profusa: Develops injectable, hydrogel-based biosensors that continuously monitor multiple analytes in interstitial fluid for months at a time. Comparable miniaturized, long-duration continuous biosensor platform targeting chronic disease.
  • Viome: Saliva- and stool-based diagnostics company focused on gut microbiome, chronic disease and cancer detection. Most directly comparable saliva-based diagnostics peer, though Viome uses episodic lab testing versus Lura's continuous in-mouth sensor.
  • Hagar Technology: Develops GWave, a non-invasive RF-based continuous glucose monitor. Directly comparable as a non-invasive continuous glucose alternative to Lura's saliva-based approach.
  • Abbott (FreeStyle Libre): Sells the FreeStyle Libre CGM line, the largest installed-base continuous glucose monitor globally. Comparable to Lura in continuous biomarker tracking for diabetes management and chronic disease.

Emerging players

  • Bowhead Health: Early-stage saliva-based diagnostics company developing at-home saliva tests for hormone and wellness biomarkers. Comparable diagnostic fluid (saliva) and consumer health focus, but episodic rather than continuous.

Broad incumbents

  • Medtronic: Diversified medical device leader with connected diabetes (MiniMed CGM and pumps) and broader patient monitoring portfolio. Comparable as a broad incumbent pursuing connected chronic disease monitoring at scale.
  • Colgate-Palmolive: Global oral care leader publicly aligned with Lura (via Dr. Maria Ryan at CareQuest showcase) and actively pursuing oral-systemic health integration. Comparable as a potential OEM channel partner and adjacent oral-health hardware player.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights6 records

Customer concentration

Lura Health social profiles

Digital presence

Lura Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lura Health leadership team

Management profile

Number of profiles

Profiles7 records

Lura Health funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lura Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lura Health

What does Lura Health do?

Lura Health is developing a non-invasive, miniaturized microbiosensor worn in the mouth that continuously records salivary analytes (glucose, electrolytes, biologics) related to chronic disease and transmits the data to a smartphone via Bluetooth Low Energy. The sensor can be integrated into existing dental hardware such as aligners, retainers, sports guards, brackets, dentures, crowns, and bridges, or attached directly to a tooth for up to 18 months, with readings linked to electronic medical records for clinician review. The product is currently in development and is not yet approved for sale or distribution in the USA.

Is Lura Health a public or private company?

Lura Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Lura Health founded?

Lura Health was founded in 2020. It employs 1 to 10 people.

Where is Lura Health based?

Lura Health is headquartered in Cambridge, United States, in the North America region.

How does Lura Health make money?

Three revenue lines are on record. Hardware Device Sales are the primary driver. The others are data/Analytics Services and OEM/Embedded Licensing.

Who are Lura Health's main competitors?

Direct peers on record are Senseonics, Dexcom, Biolinq, Profusa, Viome, Hagar Technology and Abbott (FreeStyle Libre). Bowhead Health is listed as an emerging player. Broad incumbents are Medtronic and Colgate-Palmolive.

Does Lura Health have an API?

No public API is recorded for Lura Health.

What industry is Lura Health in?

Lura Health's product category is Wearable Medical Biosensors. Its primary akta.pro industry code is HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FittLura Health Scales Invisible Saliva SensorsLura Health has secured investment from Japanese dental technology firm SCO Group to expand the clinical use cases for its invisible saliva sensors. The company aims to achieve FDA clearance by 2027 and will leverage SCO Group’s infrastructure to pursue public health initiatives in oral health, diabetes, and drug monitoring across Asia, starting with Japan.NJBIZLura Health partners with Japan’s SCO Group on Asia expansionLura Health announced a partnership with Japan-based SCO Global to deploy its intraoral salivary monitoring sensors in Asian clinical settings, with pilot projects launching this fall. The collaboration aims to integrate Lura's biosensing technology with SCO's dental infrastructure to establish a new preventative care model in Japan while targeting FDA approval by early 2027.YahooLura Health Announces Strategic Investment and Business Partnership with SCO Group to Advance Intraoral Health MonitoringLura Health announced a partnership with SCO Group to deploy its intraoral salivary monitoring sensors in Japan, targeting FDA approval by early 2027. The collaboration integrates sensors with SCO's Pay Light X platform, with joint pilot projects expected this fall. Future applications include sports performance, eldercare, and wellness.MatterStartup Spotlight: Lura HealthLura Health, founded by Daniel Weinstein, Saam Bozorg and Noah Hill at Tufts University, is developing medical-grade, non-invasive wearables that monitor health biomarkers in saliva rather than blood or interstitial fluid. The company has raised nearly $5 million, completed a first-in-human clinical study, and secured Letters of Intent from dental and private companies.LinkedInLura Health is proud to announce that we have been selected as the recipient of a $200,000 grant from the National Science Foundation (NSF).Lura Health received a $200,000 NSF grant and partnered with PATHS-UP Engineering Research Center at Texas A&M. The collaboration, under the SECO program, aims to validate and optimize sensor performance with university students and Lura Health staff.ForbesLura HealthLura Health, founded by Daniel Weinstein and Noah Hill, has developed wireless intra-oral sensors mounted on teeth to track diagnostics via saliva. The company's initial products focus on monitoring acid levels to detect tooth decay, with future plans to expand capabilities to allergens, electrolytes, hormones, and disease markers.